155 related articles for article (PubMed ID: 10698478)
1. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.
Rao JY; Apple SK; Jin Y; Lin S; Nieberg RK; Hirtschowitz SL
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):175-9. PubMed ID: 10698478
[TBL] [Abstract][Full Text] [Related]
2. Single cell multiple biomarker analysis in archival breast fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA content, p53, and G-actin as breast cancer biomarkers.
Rao JY; Apple SK; Hemstreet GP; Jin Y; Nieberg RK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1027-33. PubMed ID: 9829712
[TBL] [Abstract][Full Text] [Related]
3. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
4. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
5. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
6. Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.
Fabian CJ; Zalles C; Kamel S; Zeiger S; Simon C; Kimler BF
J Cell Biochem Suppl; 1997; 28-29():101-10. PubMed ID: 9589354
[TBL] [Abstract][Full Text] [Related]
7. MYC amplification and TERT expression in breast tumor progression.
Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE
Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250
[TBL] [Abstract][Full Text] [Related]
8. Abnormal FHIT gene transcript and c-myc and c-erbB2 amplification in breast cancer.
Kowara R; Gołebiowski F; Chrzan P; Skokowski J; Karmolinski A; Pawełczyk T
Acta Biochim Pol; 2002; 49(2):341-50. PubMed ID: 12362975
[TBL] [Abstract][Full Text] [Related]
9. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.
Bitzer M; Stahl M; Arjumand J; Rees M; Klump B; Heep H; Gabbert HE; Sarbia M
Anticancer Res; 2003; 23(2B):1489-93. PubMed ID: 12820414
[TBL] [Abstract][Full Text] [Related]
10. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
[TBL] [Abstract][Full Text] [Related]
11. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay.
Yu Q; Niu Y; Yu Y; Ding X; Shi Y
Breast Cancer Res Treat; 2009 Apr; 114(3):433-40. PubMed ID: 18425676
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma.
Bofin AM; Ytterhus B; Martin C; O'Leary JJ; Hagmar BM
Am J Clin Pathol; 2004 Jul; 122(1):110-9. PubMed ID: 15272539
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features.
Cericatto R; Pozzobon A; Morsch DM; Menke CH; Brum IS; Spritzer PM
Steroids; 2005 Mar; 70(3):153-60. PubMed ID: 15763593
[TBL] [Abstract][Full Text] [Related]
15. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
Abou-Elella A; Gramlich T; Fritsch C; Gansler T
Mod Pathol; 1996 Feb; 9(2):95-8. PubMed ID: 8657726
[TBL] [Abstract][Full Text] [Related]
16. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
18. Semi-quantitative RT-PCR assessment of molecular markers in breast large-core needle biopsies.
Pohlodek K; Galbavý S; Bartosová M; Mucha V; Holomán K; Pastorek J; Pastoreková S
Neoplasma; 2004; 51(6):415-21. PubMed ID: 15640949
[TBL] [Abstract][Full Text] [Related]
19. Assessing sequential oncogene amplification in human breast cancer.
Janocko LE; Lucke JF; Groft DW; Brown KA; Smith CA; Pollice AA; Singh SG; Yakulis R; Hartsock RJ; Shackney SE
Cytometry; 1995 Sep; 21(1):18-22. PubMed ID: 8529465
[TBL] [Abstract][Full Text] [Related]
20. c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers.
Park K; Kwak K; Kim J; Lim S; Han S
Hum Pathol; 2005 Jun; 36(6):634-9. PubMed ID: 16021569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]